Meningitis

Health Protection Agency licenses meningitis patent to chiron

Published in TB and Outbreaks Week, November 18th, 2003

The U.K. Health Protection Agency (HPA) has concluded a deal in which it has licensed the rights to a patent for the manufacture of a multicomponent meningitis B vaccine to Chiron Vaccines. This fulfils a strategic goal of the agency to develop its intellectual assets in partnership with industry to benefit U.K. health protection.

The deal provides Chiron with an exclusive royalty-bearing license while enabling the HPA to continue its research and development activities in the field. In return, Chiron will pay the HPA a signing-on fee, with other terms of the agreement including milestone payments for product development through to market and a royalty income from any...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2003-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry